References
- Khachaturian H., Lewis M. E., Schafer M. K.H., Watson S. J. Anatomy of the CNS opioid systems. Trends in Neurosciences 1985; 8: 111–119
- Van Wimersma Greidanus T. B., ten Haaf J. A. Opioids and the posterior pituitary. Opioid modulation of endocrine function, G. Delitalla, M. Motta, M. Serio. Raven Press, New York 1984; 125–136
- Kakidani H., Furutani Y., Takahashi H., Noda M., Morimoto Y., Hirose T., Asai M., Inayama S., Nakanishi S., Numa S. Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor. Nature 1982; 298: 245–249
- Imura H., Kato Y., Nakai Y., Nakao K., Inagami H., Tanaka I., Koh T., Tsukada T., Yoshimasa T., Suda M., Sakamoto M., Morii N., Takahashi H., Tojo K., Sugawara A. Endogenous opioid and related peptides: from molecular biology to clinical medicine. J Endocr 1985; 107: 147–157
- Suda M., Nakao K, Yoshimasa T., Ikeda Y., Sakamoto M., Yanaihara N., Numa S., Imura H. A novel opioid peptide leumorphin, acts as an agonist at the k opiate receptor. Life Sci 1983; 32: 2769–2775
- Nakao K., Suda M., Sakamoto M., Yoshimasa T., Morii N., Ikeda Y., Yanaihara C., Yanaihara N., Numa S., Imura H. Leumorphin is a novel endogenous opioid peptide derived from proenkephalin B. Biochem Biophys Res Commun 1983; 117: 695–701
- Suda M., Nakao K., Sakamoto M., Yoshimasa T., Morii N., Yanaihara N., Numa S., Imura H. Leumorphin in human brain. Neuropeptides 1985; 5: 461–464
- Imura H., Nakao K., Yanaihara N., Katsuura G., Nakamura M. Potent action of leumorphin on consummatory behavior in rats: comparison with other opioid peptides. Neuroendocrinology 1986; 44: 142–148
- Itoh H., Nakao K., Yamada T., Morii N., Shiono S., Sakamoto M., Sugawara A., Saito Y., Mukoyama M., Arai H., Imura H. Potent depressor action of leumorphin a K-opioid agonist, in conscious rats. Am J Hypertens 1988, in press
- Yamada T., Nakao K., Itoh H., Morii N., Shiono S., Sakamoto M., Sugawara A., Saito Y., Mukoyama M., Arai H., Eigyo M., Matsushita A., Imura H. Inhibitory action of leumorphin on vasopressin secretion in conscious rats. Endocrinology 1988; 122: 985–990
- Watson S. J., Akil H., Fischli W., Goldstein A., Zimmerman E. A., Nilaver G., van Wimersma Greidanus T. B. Dynorphin and vasopressin: common localization in magnocellular neurons. Science 1982; 216: 85–87
- Yamada T., Nakao K., Morii N., Itoh H., Shiono S., Sakamoto M., Sugawara A., Saito Y., Ohno H., Kanai A., Katsuura G., Eigyo M., Matsushita A., Imura H. Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopression secretion in conscious rats. Eur J Pharmacol 1986; 125: 452–456
- Rockhold R. W., Crofton J. T., Brooks D. P., Share L. Naloxone dose not improve cardiovascular or blunt vasopressin release in spontaneously hypertensive rats following graded hemorrhage. Neuroendocrinology 1986; 43: 657–663
- Knepel W., Nutto D., Anhut H., Hertting G. Naloxone promotes stimulus-evoked vasopressin release in vivo. Eur J Pharmacol 1980; 65: 449–450